Allergy Therapeutics plc (LON:AGY – Get Free Report)’s stock price hit a new 52-week high on Friday . The stock traded as high as GBX 9 and last traded at GBX 9, with a volume of 312497 shares changing hands. The stock had previously closed at GBX 8.50.
Allergy Therapeutics Trading Up 2.7%
The stock has a fifty day simple moving average of GBX 8.22 and a 200 day simple moving average of GBX 7.79. The firm has a market capitalization of £536.15 million, a P/E ratio of -12.13, a PEG ratio of -30.70 and a beta of 1.40. The company has a quick ratio of 1.48, a current ratio of 1.63 and a debt-to-equity ratio of 835.48.
About Allergy Therapeutics
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Featured Articles
- Five stocks we like better than Allergy Therapeutics
- What Investors Need to Know to Beat the Market
- Netflix Stock Split Explained: What It Means for Investors
- Breakout Stocks: What They Are and How to Identify Them
- SoundHound Beat Earnings & Dropped—Here’s What Wall Street Missed
- What is the Australian Securities Exchange (ASX)
- AI Trade Over? Datadog Results Say It’s Gaining Momentum
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
